Food and Drug Administration (FDA) approved a new indication for semaglutide to reduce cardiovascular risk in adults with established cardiovascular disease (CVD) and overweight or obesity
Metsera claims that MET-097 has dual agonist-like weight loss at 36 weeks, I want to pump the brakes on that right now
Vitamin B12 Injection for Dogs Cats and Livestock
It's worth noting that GLP-1 receptor agonists are not recommended in patients with severe gastrointestinal disease, such as severe gastroparesis, as stated in the SmPC
#3: Optimize Vitamin D Status (CRITICAL) Test: Measure 25-OH vitamin D Optimal range: 40-60 ng/mL (many practitioners target 50-80 ng/mL for neurological conditions) Supplement: Adults: 2,000-5,000 IU daily
Mattioli : The majority of our patients show gastrointestinal side effects like nausea, vomiting, constipation, and diarrhea